康希诺(688185)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

研究机构 评级日期 最新评级 上次评级
浙商证券 2023-12-28 增持
  盈利预测
据康希诺三季报分析:

  盈利能力维持稳定,企业经营效益亏损加重

  成长能力维持稳定,营业收入下滑趋势减缓

  偿债能力有所削弱,短期偿债能力具有一定的保障

  运营能力维持稳定,存货的周转速度需要加快

  现金流能力有所加强,公司现金回收质量较高

  财务数据
    截至第三季度实现净利润-14.55亿元,每股收益-3.99元。

    截至第三季度最新股东权益579824.82万元,未分配利润-106071.12万元。

    截至第三季度最新总资产961064.24万元,负债381239.42万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入175,631,799.925,907,807.5100,553,0001,034,595,000
营业总成本941,841,563.33635,641,318.66338,230,0001,554,635,000
营业利润-1,415,383,868.45-1,241,332,061.33-192,347,000-1,180,706,000
利润总额-1,456,083,746.67-1,283,335,401.84-200,466,000-1,184,001,000
净利润-1,454,919,925.84-1,282,171,580.55-170,199,000-964,757,000
其他综合收益122,813.38147,781.5733,000121,000
综合收益总额-1,454,797,112.46-1,282,023,798.98-170,166,000-964,636,000
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计5,527,055,428.525,928,024,152.727,320,581,0007,730,184,538.12
非流动资产合计4,083,586,996.783,969,247,026.583,894,808,0003,738,773,748.59
资产总计9,610,642,425.39,897,271,179.311,215,389,00011,468,958,286.71
流动负债合计2,465,480,812.52,716,158,241.132,620,183,0002,924,706,973.66
非流动负债合计1,346,913,411.011,211,855,067.91,517,171,0001,298,649,587.86
负债合计3,812,394,223.513,928,013,309.034,137,354,0004,223,356,561.52
归属于母公司股东权益合计5,770,626,650.095,912,488,550.946,611,175,0006,748,089,902.12
股东权益合计5,798,248,201.795,969,257,870.277,078,035,0007,245,601,725.19
负债和股东权益合计9,610,642,425.39,897,271,179.311,215,389,00011,468,958,286.71
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计615,809,046.71277,157,465.16140,298,000879,329,000
经营活动现金流出小计1,364,783,068.461,014,560,615.82485,702,0002,730,874,000
经营活动产生的现金流量净额-748,974,021.75-737,403,150.66-345,404,000-1,851,545,000
投资活动现金流入小计6,640,825,701.634,033,537,610.522,787,236,00012,212,117,000
投资活动现金流出小计6,852,600,669.224,109,557,139.232,959,245,00013,439,758,000
投资活动产生的现金流量净额-211,774,967.59-76,019,528.71-172,009,000-1,227,641,000
筹资活动现金流入小计1,373,508,403.11,053,830,190.76409,925,0002,634,351,000
筹资活动现金流出小计1,504,827,902.751,284,446,241.64420,400,0001,780,117,000
筹资活动产生的现金流量净额-131,319,499.65-230,616,050.88-10,475,000854,234,000
汇率变动对现金及现金等价物的影响51,795,363.5736,817,906.68-19,486,000160,764,000
现金及现金等价物净增加额-1,040,273,125.42-1,007,220,823.57-547,374,000-2,064,188,000
期末现金及现金等价物余额2,350,994,729.852,384,047,031.72,843,894,0003,391,268,000
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点

    截至第三季度实现净利润-14.55亿元,每股收益-3.99元。

    截至第三季度最新股东权益579824.82万元,未分配利润-106071.12万元。

    截至第三季度最新总资产961064.24万元,负债381239.42万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入175,631,799.925,907,807.5100,553,0001,034,595,000
营业总成本941,841,563.33635,641,318.66338,230,0001,554,635,000
营业利润-1,415,383,868.45-1,241,332,061.33-192,347,000-1,180,706,000
利润总额-1,456,083,746.67-1,283,335,401.84-200,466,000-1,184,001,000
净利润-1,454,919,925.84-1,282,171,580.55-170,199,000-964,757,000
其他综合收益122,813.38147,781.5733,000121,000
综合收益总额-1,454,797,112.46-1,282,023,798.98-170,166,000-964,636,000
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计5,527,055,428.525,928,024,152.727,320,581,0007,730,184,538.12
非流动资产合计4,083,586,996.783,969,247,026.583,894,808,0003,738,773,748.59
资产总计9,610,642,425.39,897,271,179.311,215,389,00011,468,958,286.71
流动负债合计2,465,480,812.52,716,158,241.132,620,183,0002,924,706,973.66
非流动负债合计1,346,913,411.011,211,855,067.91,517,171,0001,298,649,587.86
负债合计3,812,394,223.513,928,013,309.034,137,354,0004,223,356,561.52
归属于母公司股东权益合计5,770,626,650.095,912,488,550.946,611,175,0006,748,089,902.12
股东权益合计5,798,248,201.795,969,257,870.277,078,035,0007,245,601,725.19
负债和股东权益合计9,610,642,425.39,897,271,179.311,215,389,00011,468,958,286.71
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计615,809,046.71277,157,465.16140,298,000879,329,000
经营活动现金流出小计1,364,783,068.461,014,560,615.82485,702,0002,730,874,000
经营活动产生的现金流量净额-748,974,021.75-737,403,150.66-345,404,000-1,851,545,000
投资活动现金流入小计6,640,825,701.634,033,537,610.522,787,236,00012,212,117,000
投资活动现金流出小计6,852,600,669.224,109,557,139.232,959,245,00013,439,758,000
投资活动产生的现金流量净额-211,774,967.59-76,019,528.71-172,009,000-1,227,641,000
筹资活动现金流入小计1,373,508,403.11,053,830,190.76409,925,0002,634,351,000
筹资活动现金流出小计1,504,827,902.751,284,446,241.64420,400,0001,780,117,000
筹资活动产生的现金流量净额-131,319,499.65-230,616,050.88-10,475,000854,234,000
汇率变动对现金及现金等价物的影响51,795,363.5736,817,906.68-19,486,000160,764,000
现金及现金等价物净增加额-1,040,273,125.42-1,007,220,823.57-547,374,000-2,064,188,000
期末现金及现金等价物余额2,350,994,729.852,384,047,031.72,843,894,0003,391,268,000
  十大流通股东
十大流通股东 报告期:2023-09-30
股东名称 持股数量(万股) 占总股本比例(%) 上期持股变化(万股)
香港中央结算(代理人)有限公司9806.6939.63-0.06
XUEFENG YU(宇学峰)1787.427.221787.42
朱涛1787.427.221787.42
DONGXU QIU(邱东旭)1711.426.921711.42
HELEN HUIHUA MAO(毛慧华)1519.546.141519.54
天津千益企业管理合伙企业(有限合伙)347.461.40347.46
天津千睿企业管理合伙企业(有限合伙)329.951.33329.95
先进制造产业投资基金(有限合伙)288.381.170.00
孙戈140.370.570.00
中国银行股份有限公司-招商国证生物医药指数分级证券投资基金129.200.524.35
  主力控盘
  公司简介
康希诺 所属地域: 天津市 涉及概念: 沪股通,MSCI概念,生物疫苗,融资融券
主营业务: 化学药品、生物药品、疫苗和诊断试剂的研发、技术转让,生产(凭许可证开展经营活动),并提供技术咨询服务;化学品、生物制品及耗材的批发(食品、药品、危险化学品及易燃、易爆、易制毒品除外)、进出口。(依法须经批准的项目,经相关部门批准后方可开展经营活动)。
上市日期: 2020-08-13 每股净资产: 23.32元 每股收益: -3.99元 净利润: -9.85亿元 净利润增长率: -107.63%
营业收入: 1.76亿元 每股现金流: -3.03元 每股公积金: 26.56元 每股未分配利润: -4.29元 总股本: 2.47亿 流通股: 1.15亿
以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心